1181 pharmaceutical jobs found in San Rafael, CA

Pharmaceutical Sales Territory Representative As one of our Pharmaceutical Sales Representatives (Entry level / Experienced) you will manage and develop long-term relationships with physicians and other healthcare professionals for the customer accounts in your geographic territory. As such, each Pharmaceutical Sales Rep will represent the assigned brand products and their approved indications; helping external customers such as physicians, nurses, etc. learn about the benefits of the assigned healthcare and pharmacology products in relation to the applicable therapeutic area or disease state. We are looking to add to our strong, customer-focused Pharmaceutical Sales Rep team who will represent our products with integrity and conviction. Interested Pharmaceutical Sales Rep (Entry level / Experienced) candidates should demonstrate the following: You have some sales experience with good sales abilities and have the entrepreneurial spirit and drive to help grow our...

Pharmaceutical Sales Rep Opening Summary: We are seeking driven, collaborative, and positive sales leaders to build out and lead the product launch of a few new and innovative pharmaceutical products. If you are looking to enter the fast growing career of being a Pharmaceutical Sales Rep then this might be the job for you. The Pharmaceutical Sales Rep will be the primary selling agent within an assigned territory. Reporting to a National Sales Manager, the Pharmaceutical Sales Rep role will be responsible for providing current and comprehensive knowledge of pharmaceutical products in the Primary Care and some Specialty Physician space while simultaneously supporting the organizations mission and values. Responsibilities for our Pharmaceutical Sales Rep professional: Uphold and model competencies that are key to the organizations culture including integrity, drive, accountability, flexibility, and perseverance Meet or exceed assigned territory sales goals...

WHO WE ARE: Avion Pharmaceuticals is a leading specialty pharmaceutical company focused on women's healthcare and rheumatology segments of the U.S. We are a fully integrated company with internal resources dedicated to the development, manufacturing, and promotion of its products. We have developed strong franchises in women's healthcare and rheumatology through our marketing efforts and training of our specialty sales forces. We believe that our proven product development and customer focused marketing and sales efforts distinguish Avion Pharmaceuticals as the "Gold Standard" company in our respective therapeutic categories. We are expecting to launch several new products to further distinguish ourselves as the market leader in Women's Health. When you're searching for an employer that will help you thrive, the best resource you must gauge employer performance is the opinion of its team. Avion Pharmaceuticals is proud to announce we've been recognized as the small pharma...

WHO WE ARE: Avion Pharmaceuticals is a leading specialty pharmaceutical company focused on women's healthcare and rheumatology segments of the U.S. We are a fully integrated company with internal resources dedicated to the development, manufacturing, and promotion of its products. We have developed strong franchises in women's healthcare and rheumatology through our marketing efforts and training of our specialty sales forces. We believe that our proven product development and customer focused marketing and sales efforts distinguish Avion Pharmaceuticals as the "Gold Standard" company in our respective therapeutic categories. We are expecting to launch several new products to further distinguish ourselves as the market leader in Women's Health. When you're searching for an employer that will help you thrive, the best resource you must gauge employer performance is the opinion of its team. Avion Pharmaceuticals is proud to announce we've been recognized as the small pharma...

Compensation $45,000 Annually (plus commission) Benefits Offered 401K, Dental, Life, Medical, Vision Employment Type Full-Time We are seeking an Entry Level Pharmaceutical Sales Representative to join our team! You will resolve customer questions and offer solutions to drive company revenue. Responsibilities: Present and sell company products and services to new and existing customers (ortho/podiatry/family practice) Prospect and contact potential customers Reach agreed upon sales targets by the deadline (very goal specific) Resolve customer inquiries and complaints Set follow-up appointments to keep customers aware of latest developments Create sales material to present to customers ​ Qualifications: Previous experience in sales, customer service, or other related fields Able to work large geography Familiarity with CRM platforms Ability to build rapport with clients Strong negotiation skills Deadline and detail-oriented...

Genentech, a member of the Roche group and founder of the biotechnology industry, is dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. To solve the world's most complex health challenges, we ask bigger questions that challenge our industry and the boundaries of science to transform society. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. Diversity and Inclusion (D&I) are critical to the success of our company and our impact on society. We believe that by championing diversity of background, thought and experience, we can foster a sense of belonging and provide an environment where every employee feels valued, included, and able to contribute their best for the patients we serve. We’re focused on attracting, retaining, developing and advancing our people to their full potential by rewarding...

The Clinical Specialist is responsible for calling on practicing physicians, hospitals, clinics and other health-related organizations within an assigned territory.  The Clinical Specialist must provide the healthcare professional with the most current information pertaining to Indivior products and their approved indications in a manner which will ensure the appropriate use of these products and achieve the business potential of the territory.  Accomplishments of these goals must comply with the terms and conditions outlined in the Company Policy and Procedure Manual. ESSENTIAL FUNCTIONS:   The responsibilities of this job include, but are not limited to, the following: Invest the time and the effort to achieve the established goals for the territory such as sales, market share, doctor calls, appropriate program planning, etc. Monitoring and analyzing results on territory, maintaining an up to date business plan that evaluates sales...

Each one of our professional  Pharmaceutical Sales Representatives targets, promotes and sells pharmaceutical and healthcare products to Physicians and other specialized medical or healthcare providers.  If you join our team as a Pharmaceutical Sales Representative you will manage his/her territory in order to maintain existing physician groups and develop relationships with new physician groups to achieve objectives. As a member of the Pharmaceutical Sales Rep team, you will work closely with management and other groups to achieve sales goals and objectives. Our company provides quality consultative service, coordinate and integrate outside alliances, as well as other internal personnel and resources to fit customer needs.    Are you looking for a patient-focused, innovation-driven company that will inspire you and support your Pharmaceutical Sales Rep career? If so, be empowered to take charge of your future and join us as a Primary Care --...

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At Bayer you have the opportunity to be part of a culture where we value the passion of our employees to innovate and give them the power to change. Bayer is an Equal Opportunity Employer/Disabled/Veterans

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercialises innovative medicines in areas of unmet medical need. With each new discovery and investigational drug candidate, we seek to improve the care of patients living with life-threatening diseases around the world. Gilead’s therapeutic areas of focus include HIV/AIDS, liver diseases, cancer and inflammation, and serious respiratory and cardiovascular conditions. Gilead Sciences is continuing to hire for all open roles. Our interview process may be conducted virtually and some roles will be asked to temporarily work from home. Over the coming weeks and months, we will be implementing a phased approach to bringing employees back to site to ensure the health and safety of our teams. As an equal opportunity employer, Gilead Sciences Inc. is committed to a diverse workforce. Employment decisions regarding recruitment and selection will be made without discrimination based...

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercialises innovative medicines in areas of unmet medical need. With each new discovery and investigational drug candidate, we seek to improve the care of patients living with life-threatening diseases around the world. Gilead’s therapeutic areas of focus include HIV/AIDS, liver diseases, cancer and inflammation, and serious respiratory and cardiovascular conditions. Gilead Sciences is continuing to hire for all open roles. Our interview process may be conducted virtually and some roles will be asked to temporarily work from home. Over the coming weeks and months, we will be implementing a phased approach to bringing employees back to site to ensure the health and safety of our teams. As an equal opportunity employer, Gilead Sciences Inc. is committed to a diverse workforce. Employment decisions regarding recruitment and selection will be made without discrimination based...

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercialises innovative medicines in areas of unmet medical need. With each new discovery and investigational drug candidate, we seek to improve the care of patients living with life-threatening diseases around the world. Gilead’s therapeutic areas of focus include HIV/AIDS, liver diseases, cancer and inflammation, and serious respiratory and cardiovascular conditions. Gilead Sciences is continuing to hire for all open roles. Our interview process may be conducted virtually and some roles will be asked to temporarily work from home. Over the coming weeks and months, we will be implementing a phased approach to bringing employees back to site to ensure the health and safety of our teams. As an equal opportunity employer, Gilead Sciences Inc. is committed to a diverse workforce. Employment decisions regarding recruitment and selection will be made without discrimination based...

With accelerated review underway in the United States and Europe for our Hemophilia A drug, a second gene therapy program entering the clinic for PKU patients, and a third program in late research for Hereditary Angioedema, BioMarin continues to pioneer innovative approaches to treating rare diseases. Our commitment to gene therapy is further underscored by having developed the first and largest gene therapy manufacturing facility in the world. The scientific possibilities and the hope we offer to patients with rare diseases is enormous. BioMarin is a midsize biotechnology company with a market cap of approximately 18 billion. Over the course of our 22 year history we have successfully launched 7 drugs for the treatment of rare diseases. Our success is due to our scientific rigor and our ability to leverage multiple therapeutic modalities. BioMarin is based in the San Francisco Bay Area and offers a comprehensive relocation program. BioMarin is the world leader in...

With accelerated review underway in the United States and Europe for our Hemophilia A drug, a second gene therapy program entering the clinic for PKU patients, and a third program in late research for Hereditary Angioedema, BioMarin continues to pioneer innovative approaches to treating rare diseases. Our commitment to gene therapy is further underscored by having developed the first and largest gene therapy manufacturing facility in the world. The scientific possibilities and the hope we offer to patients with rare diseases is enormous. BioMarin is a midsize biotechnology company with a market cap of approximately 18 billion. Over the course of our 22 year history we have successfully launched 7 drugs for the treatment of rare diseases. Our success is due to our scientific rigor and our ability to leverage multiple therapeutic modalities. BioMarin is based in the San Francisco Bay Area and offers a comprehensive relocation program. BioMarin is the world leader in...

With accelerated review underway in the United States and Europe for our Hemophilia A drug, a second gene therapy program entering the clinic for PKU patients, and a third program in late research for Hereditary Angioedema, BioMarin continues to pioneer innovative approaches to treating rare diseases. Our commitment to gene therapy is further underscored by having developed the first and largest gene therapy manufacturing facility in the world. The scientific possibilities and the hope we offer to patients with rare diseases is enormous. BioMarin is a midsize biotechnology company with a market cap of approximately 18 billion. Over the course of our 22 year history we have successfully launched 7 drugs for the treatment of rare diseases. Our success is due to our scientific rigor and our ability to leverage multiple therapeutic modalities. BioMarin is based in the San Francisco Bay Area and offers a comprehensive relocation program. BioMarin is the world leader in...

With accelerated review underway in the United States and Europe for our Hemophilia A drug, a second gene therapy program entering the clinic for PKU patients, and a third program in late research for Hereditary Angioedema, BioMarin continues to pioneer innovative approaches to treating rare diseases. Our commitment to gene therapy is further underscored by having developed the first and largest gene therapy manufacturing facility in the world. The scientific possibilities and the hope we offer to patients with rare diseases is enormous. BioMarin is a midsize biotechnology company with a market cap of approximately 18 billion. Over the course of our 22 year history we have successfully launched 7 drugs for the treatment of rare diseases. Our success is due to our scientific rigor and our ability to leverage multiple therapeutic modalities. BioMarin is based in the San Francisco Bay Area and offers a comprehensive relocation program. BioMarin is the world leader in...

With accelerated review underway in the United States and Europe for our Hemophilia A drug, a second gene therapy program entering the clinic for PKU patients, and a third program in late research for Hereditary Angioedema, BioMarin continues to pioneer innovative approaches to treating rare diseases. Our commitment to gene therapy is further underscored by having developed the first and largest gene therapy manufacturing facility in the world. The scientific possibilities and the hope we offer to patients with rare diseases is enormous. BioMarin is a midsize biotechnology company with a market cap of approximately 18 billion. Over the course of our 22 year history we have successfully launched 7 drugs for the treatment of rare diseases. Our success is due to our scientific rigor and our ability to leverage multiple therapeutic modalities. BioMarin is based in the San Francisco Bay Area and offers a comprehensive relocation program. BioMarin is the world leader in...

With accelerated review underway in the United States and Europe for our Hemophilia A drug, a second gene therapy program entering the clinic for PKU patients, and a third program in late research for Hereditary Angioedema, BioMarin continues to pioneer innovative approaches to treating rare diseases. Our commitment to gene therapy is further underscored by having developed the first and largest gene therapy manufacturing facility in the world. The scientific possibilities and the hope we offer to patients with rare diseases is enormous. BioMarin is a midsize biotechnology company with a market cap of approximately 18 billion. Over the course of our 22 year history we have successfully launched 7 drugs for the treatment of rare diseases. Our success is due to our scientific rigor and our ability to leverage multiple therapeutic modalities. BioMarin is based in the San Francisco Bay Area and offers a comprehensive relocation program. BioMarin is the world leader in...

With accelerated review underway in the United States and Europe for our Hemophilia A drug, a second gene therapy program entering the clinic for PKU patients, and a third program in late research for Hereditary Angioedema, BioMarin continues to pioneer innovative approaches to treating rare diseases. Our commitment to gene therapy is further underscored by having developed the first and largest gene therapy manufacturing facility in the world. The scientific possibilities and the hope we offer to patients with rare diseases is enormous. BioMarin is a midsize biotechnology company with a market cap of approximately 18 billion. Over the course of our 22 year history we have successfully launched 7 drugs for the treatment of rare diseases. Our success is due to our scientific rigor and our ability to leverage multiple therapeutic modalities. BioMarin is based in the San Francisco Bay Area and offers a comprehensive relocation program. BioMarin is the world leader in...

With accelerated review underway in the United States and Europe for our Hemophilia A drug, a second gene therapy program entering the clinic for PKU patients, and a third program in late research for Hereditary Angioedema, BioMarin continues to pioneer innovative approaches to treating rare diseases. Our commitment to gene therapy is further underscored by having developed the first and largest gene therapy manufacturing facility in the world. The scientific possibilities and the hope we offer to patients with rare diseases is enormous. BioMarin is a midsize biotechnology company with a market cap of approximately 18 billion. Over the course of our 22 year history we have successfully launched 7 drugs for the treatment of rare diseases. Our success is due to our scientific rigor and our ability to leverage multiple therapeutic modalities. BioMarin is based in the San Francisco Bay Area and offers a comprehensive relocation program. BioMarin is the world leader in...